TORONTO, Feb. 13 /CNW/ - Medworxx, the makers of a strategic software platform that hospitals use to communicate, aggregate, and analyze knowledge, announced their continued expansion into the United States with the adoption of the Medworxx Policy & Procedure Management System and Content Management System (CMS) by regional reference lab, NorDx, in Maine. The Medworxx solution will enable NorDx to manage updates, version and approvals of their comprehensive set of documents detailing processes, procedures, and policies that meet the needs of the company and accreditation authorities.
"In search of a cost-effective approach to automating this system, NorDx found that the Medworxx family of products, in particular the Policy & Procedures Management System and CMS, would quickly meet our needs," said Denis Rochette, Director, IT for NorDx. "The Policy features would allow us to gain positive control over policy and procedure reviews and approvals as well as provide an efficient means for ensuring that employees always have the latest approved version readily accessible. The CMS provided a wonderful opportunity to not only 'package' the policies in an orderly and logical fashion but also to reorganize our Intranet and its content."
"Introduction of both the Medworxx Policy & Procedures Management System and CMS will allow us to standardize naming conventions and better understand how the documents are used. Structuring both systems to reflect this information will allow us to make accessing the documents by staff members easy and fast," says Rochette. Maine Medical Center, a member of MaineHealth and a NorDx affiliate, also purchased the Medworxx Policy & Procedure Management System and has an option to exercise the right to purchase the Medworxx Learning Management System (LMS) and Content Management System (CMS).
"We are excited to have NorDx and Maine Medical join the Medworxx family", said Dan Matlow, President & CEO, Medworxx. "The Medworxx Policy & Procedure Management System enables organizations to increase compliance, reduce costs, and increase productivity. The Medworxx solution, combining technology and best practices for hospital, is ideal for supporting large US-based Integrated Health Networks."
About NorDx
NorDx is a member of MaineHealth, the largest integrated health care provider in Maine and a recognized health care leader throughout New England. Since it was established in 1976 as the first licensed independent clinical laboratory in Maine, NorDx has grown to become a premier provider of routine and esoteric laboratory testing for New England's healthcare community. NorDx offers a comprehensive range of laboratory, consulting, and support services for physician offices, hospitals, healthcare networks, managed care organizations, long-term care providers, and employer groups.
About Maine Medical Center
Maine Medical Center (MMC) is a 606 bed non-profit community hospital for the people of central and southern Maine, and is the premier tertiary care center for northern New England. The hospital provides comprehensive inpatient services in all medical specialties. Centers of excellence are being developed in cancer care, heart care, children's services, and other areas building from existing excellence in multi-disciplinary services. MMC is also a teaching hospital, with active programs in undergraduate, graduate, and post-graduate medical education. Research, with emphasis on application to patient care, is an integral part of MMC.
About Medworxx
Founded in 2004 and publicly traded on the Toronto Venture Exchange, Medworxx (MWX: TSXV) makes a strategic software platform that hospitals use to communicate, aggregate, and analyze knowledge. Headquartered in Toronto, Ontario, Medworxx products are used by more than 200,000 people at over 230 hospitals across North America. Medworxx: our market is healthcare, our vertical is knowledge. For more information, visit www.medworxx.com.
The statements made in this Press Release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company's expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.